A survey of more than 800 biopharma executives shows that sustainability has become an increasingly important priority but that companies are struggling to achieve it and as a result are putting their business at risk.
Cytiva has introduced its Supor Prime sterilizing grade filters to address filtration needs of customers manufacturing high-concentration biologic drugs. The Supor Prime filter is designed to help drug developers achieve higher yields, reduce premature blockages, and limit the costs associated with filtration losses.
While Kite Pharma has partnered with Cytiva to develop a new cell therapy manufacturing platform, which was rolled out last month, the Gilead Sciences subsidiary isn’t stopping there in its pursuit of expertise in the production of CAR-T medicines.
Cytiva, a biopharma research and manufacturing specialist, rolled out a new cell therapy manufacturing platform the company developed as part of a collaboration with Gilead Sciences’ Kite Pharma unit.
SHANGHAI, May 10, 2024 /PRNewswire/ -- Ribobay Pharma, a leading Chinese biopharmaceutical contract research, development, and manufacturing organization (CRDMO) and a spin-off company of General Biol (Anhui) Co., Ltd, will provide cGMP-level oligonucleotide (oligo) CRDMO services to the world using Cytiva's first FlexFactory platform for oligo manufacturing.
Viral vector-based gene therapies hold immense promise for treating a multitude of diseases. However, their widespread adoption has been hindered by inefficient manufacturing methods and the absence of established standardized processes, resulting in high costs and limited accessibility for patients. Global life sciences leader, Cytiva, is bringing solutions to these challenges with its new ELEVECTA cell lines.
White Raven, a CDMO specializing in formulation and aseptic filling, has chosen Cytiva for its aseptic filling needs. Cytiva's SA25 Aseptic Filling Workcell will complete White Raven’s comprehensive drug product platform, offering flexibility to meet customers' manufacturing and development needs.
Multiply Labs Collaborates with Industry Leaders University of California San Francisco, Cytiva, Thermo Fisher Scientific and Charles River to Deliver a Successful Proof-of-Concept of Robotic Cell Therapy Manufacturing
US life sciences firm Cytiva opens new manufacturing site in Pune
Cytiva and BioCentriq, cell and gene therapy contract development and manufacturing organizations (CDMOs), have been awarded funding from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a public-private partnership to accelerate biopharmaceutical innovation.